GMED logo

Globus Medical (GMED) Company Overview

Profile

Full Name:

Globus Medical, Inc.

Sector:

Healthcare

Industry:

Medical Devices

Country:

United States

IPO:

August 3, 2012

Indexes:

Not included

Website:

http://www.globusmedical.com

Description:

Globus Medical, Inc. is a technology company headquartered in Audubon, Pennsylvania, specializing in the development, manufacturing, and distribution of medical devices for the treatment and restoration of the musculoskeletal system of patients. It was founded in 2003. All products of Globus Medical can be divided into two groups: Musculoskeletal solutions - mainly consist of implants, biomaterials, devices, and surgical instruments used in spinal fusion procedures, orthopedic, and neurosurgical procedures (RISE, RISE-L, CALIBER, CALIBER -L, ALTERA, ELSA, ELSA-ATP, SABLE, MAGNIFY, MAGNIFY-S, FORTIFY, XPand, QUARTEX, KINEX, AFFIRM, etc.). Supporting technologies - consist of surgical robotic solutions (ExcelsiusGPS, Surgimap).

Key Details

Price

$76.40

Market Cap

$10.51 B(Large cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$2.52 B(+60.62% YoY)

Annual EPS

$0.75(-29.91% YoY)

PE Ratio

101.87

Annual ROE

2.52%

Annual Debt To Equity

0.11

Beta

0.80

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 20, 2025

Recent annual earnings:

Feb 20, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 24, 25 Citizens Capital Markets
Market Perform
Feb 24, 25 Barclays
Overweight
Feb 21, 25 Wells Fargo
Overweight
Feb 21, 25 Stifel
Buy
Feb 21, 25 Needham
Hold
Feb 6, 25 Needham
Hold
Jan 10, 25 Canaccord Genuity
Buy
Jan 9, 25 Needham
Hold
Jan 9, 25 B of A Securities
Neutral
Dec 18, 24 Truist Securities
Hold

Screeners with GMED included

Growing Shares Outstanding
US stocks
High Piotroski score stocks
Most recommended stocks
Best performing stocks last 5 years
Stocks below analysts price target
Healthcare sector
All stocks
High Altman Z score stocks
Large cap stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$76.40
GMED price is $76.40

Price All-time High

$94.00
GMED price is currently -18.72% below its historical high of $94.00

Price Analysts Target

$100.00
GMED price is currently -23.60% lower than the consensus analysts' forecast

Price Today Change

-3.14%
GMED price is down -3.14% today

Price YTD Change

-7.63%
GMED price is down -7.63% since January 1st

Price 3-Year Change

+5.98%
GMED price is up +5.98% over the past 3 years

Market cap

Market Cap

$10.51 B
GMED market capitalization is $10.51 billion

Market Cap 3-Year Change

+43.53%
GMED market capitalization is up +43.53% over the past 3 years

Market Cap All-time High

$12.92 B
GMED market capitalization is currently -18.65% below its historical high of $12.92 billion

Market Cap Sector Rank

92.52%
GMED market capitalization is higher than 92.52% of companies in Healthcare sector

Technical

Beta

0.80
GMED beta is 0.80

200-day SMA

$75.80
GMED price is currently +0.79% above its 200-day simple moving average

14-day RSI

30.55
GMED 14-day relative strength index is 30.55

30-day Relative Volume

0.59
GMED 30-day relative volume is 0.59

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$2.52 B
GMED annual revenue is $2.52 billion

Annual Revenue Analysts Estimate

$2.68 B
GMED annual revenue is currently -6.04% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+60.62%
GMED annual revenue is up +60.62% year-on-year

Annual Revenue Sector Rank

86.88%
GMED annual revenue is higher than 86.88% of companies in Healthcare sector

Profit

Annual Gross Profit

$1.48 B
GMED annual gross profit is $1.48 billion

Annual Gross Margin

58.90%
GMED annual gross profit margin is 58.90%

Annual Operating Profit

$219.70 M
GMED annual operating income is $219.70 million

Annual Operating Margin

8.72%
GMED annual operating profit margin is 8.72%

Annual Net Income

$102.98 M
GMED annual net profit is $102.98 million

Annual Net Margin

4.09%
GMED annual net profit margin is 4.09%

EPS

Annual EPS

$0.75
GMED annual earnings per share is $0.75

Annual EPS Analysts Estimate

$3.45
GMED annual earnings per share is currently -78.27% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-29.91%
GMED annual earnings per share is down -29.91% year-on-year

Annual EPS Sector Rank

88.17%
GMED annual earnings per share is higher than 88.17% of companies in Healthcare sector

ROA & ROE

Annual ROA

1.99%
GMED annual return on assets is 1.99%

Annual ROE

2.52%
GMED annual return on equity is 2.52%

EBIT & EBITDA

Annual EBIT

$219.70 M
GMED annual earnings before interest & taxes is $219.70 million

Annual EBITDA

$473.73 M
GMED annual EBITDA is $473.73 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

101.87
GMED price to earnings ratio is 101.87

PE Ratio Sector Rank

92%
GMED price to earnings ratio is higher than 92% of companies in Healthcare sector

PB Ratio

PB Ratio

2.52
GMED price to book ratio is 2.52

PB Ratio Sector Rank

65.87%
GMED price to book ratio is higher than 65.87% of companies in Healthcare sector

PS Ratio

PS Ratio

4.17
GMED price to sales ratio is 4.17

PS Ratio Sector Rank

57.94%
GMED price to sales ratio is higher than 57.94% of companies in Healthcare sector

Enterprise value

Enterprise Value

$10.26 B
GMED enterprise value is $10.26 billion

Enterprise Value Sector Rank

91.76%
GMED enterprise value is higher than 91.76% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

21.66
GMED EV/EBITDA is 21.66

EV/EBITDA Sector Rank

91.9%
GMED EV/EBITDA is higher than 91.9% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

2.54
GMED annual current ratio is 2.54

Annual Quick Ratio

1.77
GMED annual quick ratio is 1.77

Leverage

Annual Debt To Equity

0.11
GMED annual debt to equity ratio is 0.11

Annual Interest Coverage Ratio

-
GMED annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

7
GMED piotroski f-score is 7

Altman Z-Score

7.10
GMED altman z-score is 7.10

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$5.25 B
GMED annual total assets is $5.25 billion

Annual Non Current Assets

$3.07 B
GMED annual long term assets is $3.07 billion

Annual Current Assets

$2.18 B
GMED annual total current assets is $2.18 billion

Annual Cash & Cash Equivalents

$784.44 M
GMED annual cash & cash equivalents is $784.44 million

Equity

Annual Book Value

$4.18 B
GMED annual book value is $4.18 billion

Annual Working Capital

$1.32 B
GMED annual working capital is $1.32 billion

Liabilities

Annual Total Liabilities

$1.07 B
GMED annual total liabilities is $1.07 billion

Annual Total Long Term Liabilities

$218.50 M
GMED annual total long term liabilities is $218.50 million

Annual Current Liabilities

$855.91 M
GMED annual total current liabilities is $855.91 million

Annual Accounts Payable

$75.12 M
GMED annual accounts payable is $75.12 million

Debt

Annual Total Debt

$537.19 M
GMED annual total debt is $537.19 million

Annual Total Debt 1-Year Change

+3.23%
GMED annual total debt is up +3.23% year-on-year

Annual Long Term Debt

$83.59 M
GMED annual long term debt is $83.59 million

Annual Short Term Debt

$453.60 M
GMED annual short term debt is $453.60 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$2.30 B
GMED annual total expenses is $2.30 billion

Annual Operating Expenses

$1.26 B
GMED annual total operating expenses is $1.26 billion

Annual Cost Of Goods Sold

$1.04 B
GMED annual cost of goods sold is $1.04 billion

Annual SGA

$981.05 M
GMED annual SGA is $981.05 million

Annual D&A

$254.02 M
GMED annual depreciation & amortization is $254.02 million

Annual Interest Expense

-
GMED annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$520.64 M
GMED annual cash flow from operations is $520.64 million

Annual CFO 1-Year Change

+113.82%
GMED annual cash flow from operations is up +113.82% year-on-year

Annual CFI

-$176.05 M
GMED annual cash flow from investing activities is -$176.05 million

Annual CFI 1-Year Change

-158.11%
GMED annual cash flow from investing activities is down -158.11% year-on-year

Annual CFF

-$27.70 M
GMED annual cash flow from financing activities is -$27.70 million

Annual CFF 1-Year Change

+88.05%
GMED annual cash flow from financing activities is up +88.05% year-on-year

Free CashFlow

Annual FCF

$405.21 M
GMED annual free cash flow is $405.21 million

Annual FCF 1-Year Change

+145.25%
GMED annual free cash flow is up +145.25% year-on-year

CAPEX

Annual CAPEX

$115.43 M
GMED annual capital expenditures is $115.43 million

Annual CAPEX 1-Year Change

+47.47%
GMED annual capital expenditures is up +47.47% year-on-year

Institutional Ownership

Similar stocks

EXEL logo
Exelixis (EXEL)
PEN logo
Penumbra (PEN)
RDY logo
Dr Reddys Laboratories Limited (RDY)
VTRS logo
Viatris (VTRS)
SRPT logo
Sarepta Therapeutics (SRPT)
AVTR logo
Avantor (AVTR)
COR logo
Cencora (COR)
UHS logo
Universal Health Services (UHS)
NBIX logo
Neurocrine Biosciences (NBIX)

FAQ

  • What is the ticker symbol for Globus Medical?
  • Does Globus Medical pay dividends?
  • What sector is Globus Medical in?
  • What industry is Globus Medical in?
  • What country is Globus Medical based in?
  • When did Globus Medical go public?
  • Is Globus Medical in the S&P 500?
  • Is Globus Medical in the NASDAQ 100?
  • Is Globus Medical in the Dow Jones?
  • When was Globus Medical's last earnings report?
  • When does Globus Medical report earnings?
  • Should I buy Globus Medical stock now?

What is the ticker symbol for Globus Medical?

The ticker symbol for Globus Medical is NYSE:GMED

Does Globus Medical pay dividends?

No, Globus Medical does not pay dividends

What sector is Globus Medical in?

Globus Medical is in the Healthcare sector

What industry is Globus Medical in?

Globus Medical is in the Medical Devices industry

What country is Globus Medical based in?

Globus Medical is headquartered in United States

When did Globus Medical go public?

Globus Medical's initial public offering (IPO) was on August 3, 2012

Is Globus Medical in the S&P 500?

No, Globus Medical is not included in the S&P 500 index

Is Globus Medical in the NASDAQ 100?

No, Globus Medical is not included in the NASDAQ 100 index

Is Globus Medical in the Dow Jones?

No, Globus Medical is not included in the Dow Jones index

When was Globus Medical's last earnings report?

Globus Medical's most recent earnings report was on Feb 20, 2025

When does Globus Medical report earnings?

The next expected earnings date for Globus Medical is May 7, 2025

Should I buy Globus Medical stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions